Georgia CTSA Clinical Research Center Supports S. Aureus Bacteremia (SAB) Treatment Clinical Trial Moving to Phase 3
“This study was run through the GCRC, utilizing nursing, phlebotomy, coordinator, and laboratory services. We couldn’t have done this fast-paced inpatient study without this group!” says Dr. Kraft. Georgia CTSA Clinical Research Centers (GCRCs) Director Colleen Kraft, MD, and Nirja Mehta, MD, were Emory site PIs for the diSArm study (NCT05184764), a Phase 2 study of the safety, tolerability, and efficacy of intravenous AP-SA02 for SAB treatment.